ArticleScientific reports2025
Correlation of exposure to volatile organic compounds with myocardial infarction: A Cross-sectional study based on NHANES 2011-2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations between volatile organic compound mixtures and allostatic load: Evidence from the Green Heart Louisville Project.Environmental research · 2026Article
- Association of volatile organic compounds with serum lactate dehydrogenase levels in the general adults.International archives of occupational and environmental health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial infarction (MI), commonly referred to as a heart attack, ranks among the foremost causes of death worldwide. The contribution of exposure to volatile organic compounds (VOCs) to MI is still not well established. This study aims to examine how urinary metabolites of 19 volatile organic compounds (mVOCs) correlate with MI risk in the ordinary population. The data were extracted from the National Health and Nutrition Examination Survey spanning from 2011 to 2018, a nationally representative program conducted by the Centers for Disease Control and Prevention (CDC) to collect and assess the health and nutritional status of the non-institutionalized U.S. population through interviews and physical examinations. The relationship between a single mVOC and MI was analyzed by applying a logistic regression model. The nonlinear relationship between a single mVOC and MI was investigated with the help of a restricted cubic spline regression model. The overall association between mVOCs and MI was examined using a weighted quantile sum (WQS) regression model. The analysis included 5,211 participants, among whom 209 experienced MI, with mVOC levels assessed. A positive association between N-acetyl-S-(3-hydroxypropyl)-L-cysteine (3HPMA) [OR, 1.95; 95% CI, (1.06, 3.58)] and MI incidence was observed after adjustment for potential confounders. Similarly, N-acetyl-S-(2-cyanoethyl)-L-cysteine (CYMA) was also significantly associated with MI incidence [OR, 1.8; 95% CI, (1.14, 2.83)]. Each incremental unit increase in WQS was linked to a 20.4% rise in MI risk (95% CI, 1.05, 1.38). Among them, N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (DHBMA), N-acetyl-S-(2-carboxyethyl)-L-cysteine (CEMA), CYMA, N-acetyl-S-(phenyl-2-hydroxyethyl)-L-cysteine (PHEMA), 3HPMA, and 3- and 4-methylhippuric acid (3,4MHA) were identified as key contributors, with DHBMA showing the highest weight (0.27). mVOCs are metabolic derivatives of VOC exposure, with common sources including industrial emissions, environmental pollution, and tobacco combustion. The findings revealed a significant association between urinary mVOCs and MI, implying exposure to these compounds may be linked to an increased MI risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.